Page last updated: 2024-08-24

nafagrel and Lupus Nephritis

nafagrel has been researched along with Lupus Nephritis in 5 studies

*Lupus Nephritis: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982). [MeSH]

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirata, D; Iwamoto, M; Kaneko, N; Masuyama, J; Minota, S; Nara, H; Okazaki, H; Yoshio, T	1
Homma, M; Ichikawa, Y; Tojo, T; Yoshida, T	1
Homma, M; Ichikawa, Y; Kameda, H; Tojo, T; Yoshida, T	1
Homma, M; Ikeda, Y; Kameda, H; Masashi, A; Yoshida, T	1
Koseki, J; Nagamatsu, T; Nagao, T; Suzuki, Y	1

Trials

2 trial(s) available for nafagrel and Lupus Nephritis

Article	Year
Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis. The Journal of rheumatology, 1996, Volume: 23, Issue:10 Topics: Adult; Enzyme Inhibitors; Female; Humans; Imidazoles; Indomethacin; Kidney; Lupus Nephritis; Middle Aged; Prostaglandins; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane-A Synthase	1996
Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in lupus nephritis. Advances in experimental medicine and biology, 1997, Volume: 433 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cross-Over Studies; Enzyme Inhibitors; Female; Humans; Imidazoles; Indomethacin; Lupus Nephritis; Male; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase	1997

Other Studies

3 other study(ies) available for nafagrel and Lupus Nephritis

Article	Year
Production of thromboxane A2 and prostaglandin i2 affected by interaction of heat aggregated IgG, endothelial cells, and platelets in lupus nephritis. The Journal of rheumatology, 2002, Volume: 29, Issue:10 Topics: Antigen-Antibody Complex; Blood Platelets; Cells, Cultured; Coculture Techniques; Complement C1q; Endothelium, Vascular; Epoprostenol; Hot Temperature; Humans; Imidazoles; Immunoglobulin G; Infant, Newborn; Lupus Nephritis; Male; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane-A Synthase	2002
Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904. Lupus, 1996, Volume: 5, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Enzyme Inhibitors; Female; Humans; Imidazoles; Kidney Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Prostaglandins; Reference Values; Regression Analysis; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase	1996
Thromboxane A(2) causes retarded clearance of aggregated protein in glomeruli of nephritic mice. European journal of pharmacology, 2001, Feb-16, Volume: 413, Issue:2-3 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antibodies; Autoantibodies; Benzenesulfonates; Cells, Cultured; Cycloheptanes; Enzyme Inhibitors; Glomerular Mesangium; Hot Temperature; Imidazoles; Kidney Glomerulus; Lupus Nephritis; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Nephritis; Receptors, Thromboxane; Serum Albumin, Bovine; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane-A Synthase; Vasoconstrictor Agents	2001